Finch Therapeutics Group Inc. (FNCH) PT Lowered to $11 at BofA Securities

May 17, 2022 9:03 AM EDT Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on Finch Therapeutics Group Inc. (NASDAQ: FNCH) to $11.00 (from $20.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login